Sanofi Share Price (NASDAQ: SNY)

$49.78

▲

-0.33

(-0.66%)

Live

Last updated on August 28, 2025 at 11:38 pm IST

$₹

Check the interactive Sanofi Stock chart to analyse performance

Sanofi stock performance

as on August 28, 2025 at 11:38 pm IST

Today's Low:$49.71
Today's High:$50.09
$49.78
0.14%
Downside
Day's Volatility :0.76%
Upside
0.62%
52 Weeks Low:$44.73
52 Weeks High:$60.12
$49.78
10.14%
Downside
52 Weeks Volatility :25.59%
Upside
17.19%

Sanofi Stock Returns

Period	Sanofi	Sector (Health Care)	Index (Russel 2000)
3 Months	-4.28%	4.2%	0.0%
6 Months	-7.44%	-8.0%	0.0%
1 Year	-10.69%	-12.1%	0.0%
3 Years	23.12%	7.6%	-6.9%

Sanofi Key Stats

Check Sanofi key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$50.11
Open	$50.31
Today's High	$50.09
Today's Low	$49.71
Market Capitalization	$123.1B
Today's Volume	$2.0M
52 Week High	$60.115
52 Week Low	$44.73
Revenue TTM	$45.7B
EBITDA	$12.1B
Earnings Per Share (EPS)	$3.01
PE Ratio	16.71
Dividend Yield	7.82%
Profit Margin	19.95%
Quarterly Earnings Growth YOY	2.67%
Return On Equity TTM	9.0%

Stock Returns calculator for Sanofi Stock including INR - Dollar returns

The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Sanofi investment value today

Current value as on today

₹93,149

Returns

₹6,851

(-6.85%)

Returns from Sanofi Stock

₹11,281 (-11.28%)

Dollar Returns*

₹4,430 (+4.43%)

Indian investors sentiment towards Sanofi Stock

9.46%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Investment in Sanofi Shares from India has grown by 9.46% over the past 30 days, indicating increased transactional activity.

-6%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Sanofi Stock from India on INDmoney has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sanofi

Name
Holdings %
Name
Holdings %
Dodge & Cox
2.94%
Fisher Asset Management, LLC
0.54%
Amvescap Plc.
0.49%
Bank of America Corp
0.43%
Capital World Investors
0.34%
Morgan Stanley - Brokerage Accounts
0.33%

Analyst Recommendation on Sanofi Stock

Rating

Trend

Buy

74%Buy

22%Hold

3%Sell

Based on 31 Wall street analysts offering stock ratings for Sanofi(by analysts ranked 0 to 5 stars)

Sanofi Share Price Target

What analysts predicted

Upside of 24.88%

Target:

$62.17

Current:

$49.78

Sanofi share price target is $62.17, a slight Upside of 24.88% compared to current price of $49.78 as per analysts' prediction.

Sanofi Stock Insights

Price Movement
In the last 7 days, SNY stock has moved down by -1.0%
Increasing Revenue
Sanofi has shown positive revenue trends over the last three quarters. Its revenue increased from $7.63 billion to $10.73 billion, reflecting an average growth of 14.6% per quarter.
Increasing Net Profit
Sanofi has shown strong performance in its net profit over the last three quarters. The net profit increased from $499.0 million to $3.94 billion, demonstrating a remarkable average growth of 62.9% per quarter.
SNY vs JNJ (1 yr)
In the last 1 year, Johnson & Johnson has given 7.9% return, outperforming this stock by 18.6%
Price to Sales
Sanofi's Price-to-Sales Ratio indicates that investors are willing to pay $2.7 for every $1 of sales generated by the company. This is lower than Johnson & Johnson, where investors are paying $4.7 for every $1 of sales. This suggests that Sanofi may be seen as a more affordable investment relative to its sales compared to Johnson & Johnson.

Sanofi Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$41.8B	↑ 5.48%
Net Income	$3.1B	↓ 34.84%
Net Profit Margin	7.46%	↓ 4.61%

	FY20	Y/Y Change
Revenue	$45.5B	↓ 0.7%
Net Income	$15.0B	↑ 338.13%
Net Profit Margin	32.9%	↑ 25.44%

	FY21	Y/Y Change
Revenue	$44.3B	↑ 4.83%
Net Income	$7.0B	↓ 49.38%
Net Profit Margin	15.89%	↓ 17.01%

	FY22	Y/Y Change
Revenue	$48.0B	↑ 15.86%
Net Income	$8.9B	↑ 34.52%
Net Profit Margin	18.44%	↑ 2.55%

	FY23	Y/Y Change
Revenue	$50.2B	↑ 1.42%
Net Income	$5.9B	↓ 35.49%
Net Profit Margin	11.73%	↓ 6.71%

	FY24	Y/Y Change
Revenue	$46.3B	↓ 3.8%
Net Income	$5.8B	↑ 2.96%
Net Profit Margin	12.55%	↑ 0.82%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$12.1B	↓ 51.41%
Net Income	$1.2B	↓ 304.14%
Net Profit Margin	10.19%	↑ 12.62%

	Q2 FY24	Q/Q Change
Revenue	$12.2B	↑ 2.36%
Net Income	$1.2B	↓ 1.77%
Net Profit Margin	9.78%	↓ 0.41%

	Q3 FY24	Q/Q Change
Revenue	$15.7B	↑ 24.4%
Net Income	$3.1B	↑ 152.92%
Net Profit Margin	19.88%	↑ 10.1%

	Q4 FY24	Q/Q Change
Revenue	$8.0B	↓ 46.1%
Net Income	$522.1M	↓ 82.27%
Net Profit Margin	6.54%	↓ 13.34%

	Q1 FY25	Q/Q Change
Revenue	$11.5B	↑ 38.99%
Net Income	$2.0B	↑ 275.15%
Net Profit Margin	17.65%	↑ 11.11%

	Q2 FY25	Q/Q Change
Revenue	$10.7B	↑ 1.22%
Net Income	$3.9B	↑ 110.47%
Net Profit Margin	36.7%	↑ 19.05%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$28.5B	↑ 5.33%

	FY20	Y/Y Change
Profit	$30.7B	↓ 1.73%

	FY21	Y/Y Change
Profit	$30.4B	↑ 6.77%

	FY22	Y/Y Change
Profit	$33.5B	↑ 17.75%

	FY23	Y/Y Change
Profit	$34.7B	↑ 0.32%

	FY24	Y/Y Change
Profit	$32.5B	↓ 2.25%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$8.3B	↓ 47.7%

	Q2 FY24	Q/Q Change
Profit	$8.6B	↑ 4.04%

	Q3 FY24	Q/Q Change
Profit	$11.2B	↑ 26.07%

	Q4 FY24	Q/Q Change
Profit	$5.6B	↓ 46.78%

	Q1 FY25	Q/Q Change
Profit	$8.3B	↑ 43.97%

	Q2 FY25	Q/Q Change
Profit	$7.7B	↑ 0.34%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$8.6B	↑ 39.08%
Investing Cash Flow	$-1.3B	↓ 90.58%
Financing Cash Flow	$-4.7B	↓ 206.58%

	FY20	Y/Y Change
Operating Cash Flow	$9.0B	↓ 3.85%
Investing Cash Flow	$4.4B	↓ 396.04%
Financing Cash Flow	$-7.9B	↑ 54.66%

	FY21	Y/Y Change
Operating Cash Flow	$11.9B	↑ 41.84%
Investing Cash Flow	$-8.3B	↓ 303.4%
Financing Cash Flow	$-8.0B	↑ 8.8%

	FY22	Y/Y Change
Operating Cash Flow	$11.1B	↑ 0.04%
Investing Cash Flow	$-2.2B	↓ 71.57%
Financing Cash Flow	$-6.2B	↓ 17.5%

	FY23	Y/Y Change
Operating Cash Flow	$11.2B	↓ 2.55%
Investing Cash Flow	$-6.8B	↑ 198.8%
Financing Cash Flow	$-8.8B	↑ 38.33%

	FY24	Y/Y Change
Operating Cash Flow	$9.5B	↓ 11.47%
Investing Cash Flow	$-4.6B	↓ 28.92%
Financing Cash Flow	$-6.0B	↓ 28.43%

Q2 FY23

Q4 FY23

Q2 FY24

Q1 FY25

	Q2 FY23	Q/Q Change
Operating Cash Flow	$3.9B	↓ 46.83%
Investing Cash Flow	$-3.3B	↑ 399.35%
Financing Cash Flow	$-5.7B	↑ 2312.5%

	Q4 FY23	Q/Q Change
Operating Cash Flow	$7.3B	↑ 87.9%
Investing Cash Flow	$-3.4B	↑ 1.66%
Financing Cash Flow	$-3.1B	↓ 45.54%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$1.5B	↑ 1517.05%
Investing Cash Flow	$-3.7B	-
Financing Cash Flow	$95.8M	↓ 88.29%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$2.3B	↑ 47.08%
Investing Cash Flow	$-839.2M	↓ 77.26%
Financing Cash Flow	$-640.2M	↓ 765.17%

Sanofi Technicals Summary

Sell

Neutral

Buy

Sanofi is currently in a neutral trading position according to technical analysis indicators.

Sanofi Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sanofi	1.54%	-7.44%	-10.69%	23.12%	-0.93%
Eli Lilly And Company	-3.77%	-18.89%	-22.63%	136.71%	394.76%
Johnson & Johnson	5.16%	7.98%	7.85%	8.46%	15.24%
Merck & Co. Inc.	1.74%	-7.19%	-28.39%	-4.02%	-1.41%
Novo Nordisk A/s	4.63%	-36.74%	-58.03%	5.06%	70.93%
Abbvie Inc	8.81%	1.48%	6.48%	53.31%	117.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sanofi	16.71	16.71	0.86	4.56	0.09	0.05	0.08	57.52
Eli Lilly And Company	47.95	47.95	1.07	22.83	0.86	0.17	0.01	20.38
Johnson & Johnson	18.88	18.88	1.07	10.85	0.3	0.08	0.03	32.6
Merck & Co. Inc.	13.1	13.1	0.83	8.93	0.35	0.13	0.04	19.57
Novo Nordisk A/s	14.15	14.15	1.62	24.84	0.79	0.22	0.03	37.82
Abbvie Inc	99.22	99.22	0.44	11.97	1.13	0.09	0.03	-0.1

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sanofi	Buy	$123.1B	-0.93%	16.71	19.95%
Eli Lilly And Company	Buy	$658.2B	394.76%	47.95	25.91%
Johnson & Johnson	Buy	$425.0B	15.24%	18.88	25.0%
Merck & Co. Inc.	Buy	$212.3B	-1.41%	13.1	25.79%
Novo Nordisk A/s	Buy	$256.0B	70.93%	14.15	35.61%
Abbvie Inc	Buy	$368.1B	117.25%	99.22	6.45%

Sanofi Dividend announcements

Sanofi Dividends June, 2025
In the quarter ending June,2025. Sanofi has declared dividend of $2.21

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, yellow fever, and rabies vaccines. In addition, the company has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as an strategic alliance with the Department of Health " Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incor

Organization	Sanofi
Employees	82878
CEO	Mr. Paul Hudson
Industry	Health Technology

Key Management of Sanofi

Name	Title
Mr. Paul Hudson	CEO & Director
Mr. François-Xavier Roger	Executive VP & CFO
Ms. Madeleine Roach	Executive VP & Head of Business Operations
Mr. Thomas Kudsk Larsen	Head of Investor Relations
Mr. Roy Papatheodorou	Executive VP & General Counsel
Mr. Pierre Chancel	Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing
Ms. Natalie Bickford	Executive VP & Chief People Officer
Mr. Olivier Charmeil	Executive Vice President of General Medicines
Fabrizio Gaudi	Head of Austrian, German & Swiss Operations
Mr. Felix Lauscher	Head of IR North America & Asia

Important FAQs about investing in SNY Stock from India :

What is Sanofi share price today?

Sanofi share price today is $49.78 as on August 28, 2025 at 11:38 pm IST. Sanofi share today touched a day high of $50.09 and a low of $49.71.

What is the 52 week high and 52 week low for Sanofi share?

Sanofi share touched a 52 week high of $60.12 and a 52 week low of $44.73. Sanofi stock price today i.e. August 28, 2025 at 11:38 pm IST is trending at $49.78, lower by 17.19% versus the 52 week high.

How to invest in Sanofi Stock (SNY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sanofi on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sanofi Shares that will get you 0.0301 shares as per Sanofi share price of $49.78 per share as on August 28, 2025 at 11:38 pm IST.

What is the minimum amount required to buy Sanofi Stock (SNY) from India?

Indian investors can start investing in Sanofi (SNY) shares with as little as ₹87.6463 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.46 in Sanofi stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Sanofi share’s latest price of $49.78 as on August 28, 2025 at 11:38 pm IST, you will get 0.2009 shares of Sanofi. Learn more about fractional shares .

What are the returns that Sanofi has given to Indian investors in the last 5 years?

Sanofi stock has given -0.93% share price returns and 18.6% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?